Christoph Grimm

ORCID: 0000-0003-2948-8129 · 4 papers in corpus
guideline 2025
Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss)
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-07974-z

Opportunistic salpingectomy is defined as the removal of both fallopian tubes as part of a surgical procedure planned for other reasons. The goal is primary prevention of ovarian cancer. The procedure is offered to patients who are not know…

other 2011
Lymphatic spread of endometriosis to pelvic sentinel lymph nodes: a prospective clinical study
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.06.070

OBJECTIVE: To establish the prevalence of endometriosis metastatic to pelvic sentinel lymph nodes (PSLN) in women with ovarian and/or peritoneal endometriosis. DESIGN: Prospective clinical study. SETTING: Academic research institution. P…

other 2009
Serum C-reactive protein in the differential diagnosis of ovarian masses
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2009.06.010

OBJECTIVE: A number of serum tumor markers have been investigated to aid clinicians in the differential diagnosis of ovarian masses. Serum C-reactive protein (CRP) is a widely used biomarker of inflammation and has been previously shown to …

nonrandomized-trial 2005
Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.04.059

In the present nonrandomized pilot study we determined the role of the vaginally administered aromatase inhibitor anastrozole (0.25 mg anastrozole/d for 6 months) in the treatment of women with histologically proven rectovaginal endometrios…